Xcout Intel
LumiraDx Ltd
LumiraDx Ltd provides diagnostic products, specifically offering rapid microfluidic immunofluorescence assays such as the SARS-CoV-2 Ag test. These in vitro diagnostic tools are designed for near-patient and clinical settings to deliver rapid, lab-comparable health results.
Subscribe to see LumiraDx Ltd’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
LumiraDx Ltd at a glance
LumiraDx Ltd is a diagnostics company headquartered in United Kingdom. It has raised at least $703.1M across the 7 funding rounds on record. Its most recent funding round raised $164M in November 2020.
LumiraDx Ltd funding rounds
At least $703.1M raised across the 7 rounds on record. The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $164M | — | |
| SEC Form D filing | $74M | — | |
| SEC Form D filing | $75.2M | — | |
| SEC Form D filing | $270M | — | |
| SEC Form D filing | $76.7M | — | |
| SEC Form D filing | $613,156 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
LumiraDx Ltd competitors
A few of LumiraDx Ltd's closest competitors — see the full list of competitors and alternatives →
Chembio Diagnostics develops and manufactures rapid point-of-care diagnostic tests for infectious diseases, tropical fever, respiratory diseases, and veterinary health.
Seegene provides molecular diagnostics products and technologies, including high-multiplex syndromic assays, automated instruments, and software systems. The company serves global healthcare and research partners by offering diagnostic solutions and a data platform for infectious disease detection and surveillance.
Immy Inc. develops, manufactures, and distributes diagnostic tests, reagents, and processing systems specializing in mycology. The company serves healthcare professionals, reference laboratories, and hospital settings by providing lateral flow assays, enzyme immunoassays, and PCR tests for the detection of fungal diseases.
Nanopath is a biotechnology and diagnostics company developing rapid molecular testing systems, with an emphasis on decentralized point-of-care testing. Its products are intended for healthcare providers and clinical laboratories, including applications in women’s health and infectious-disease diagnosis.
Linear Diagnostics Limited, trading as ExGen Dx, is a next-generation near-patient diagnostics company located at the BioHub Birmingham in Birmingham, United Kingdom.
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Get LumiraDx Ltd's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on LumiraDx Ltd in Xcout Intel
- 7 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access